<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H967EBE32D49C46669D2D6A302FFD1359" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 7384 IH: Creating Hope Reauthorization Act of 2024</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2024-02-15</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">118th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 7384</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20240215">February 15, 2024</action-date><action-desc><sponsor name-id="M001157">Mr. McCaul</sponsor> (for himself, <cosponsor name-id="E000215">Ms. Eshoo</cosponsor>, <cosponsor name-id="B001257">Mr. Bilirakis</cosponsor>, <cosponsor name-id="B001300">Ms. Barragán</cosponsor>, <cosponsor name-id="T000482">Mrs. Trahan</cosponsor>, and <cosponsor name-id="B001248">Mr. Burgess</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act to extend the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases.</official-title></form><legis-body id="H9D245E4350324AED8C43B8C0C58BB424" style="OLC"><section id="HC428C1DE88594A57B81C42F8A616488E" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Creating Hope Reauthorization Act of 2024</short-title></quote>.</text></section><section id="H7D31AE77B0F94679B6CC270894DCD634"><enum>2.</enum><header>Extension of authority to issue priority review vouchers to encourage treatments for rare pediatric diseases</header><text display-inline="no-display-inline">Section 529(b)(5) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360ff">21 U.S.C. 360ff(b)(5)</external-xref>) is amended—</text><paragraph id="H2CD12493C87748E0AED3F78846452772"><enum>(1)</enum><text>by striking <quote>September 30, 2024</quote> each place it appears and inserting <quote>September 30, 2028</quote>; and</text></paragraph><paragraph id="HC479F0424F604433B8E8574D80A7785A"><enum>(2)</enum><text>in subparagraph (B), by striking <quote>September 30, 2026</quote> and inserting <quote>September 30, 2030</quote>. </text></paragraph></section></legis-body></bill> 

